Company Website: https://www.pahc.com
TEANECK, N.J. -- (Business Wire)

Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein, dairy and petfood producers address greenhouse gas emissions through practical, science-based solutions that integrate seamlessly into existing feed and production systems.

As part of the SSP launch, Phibro is introducing Verratain™ Verified Sustainability Solutions, the Company’s first master brand for sustainable products that can significantly lower emissions across animal protein and petfood supply chains. The initial Verratain product line is being launched through a strategic partnership with VAXA Technologies and is based on VAXA Technologies’ low carbon, high value microalgae feed materials that enable efficient supply chain decarbonization.

The first two products under the Verratain brand are Verratain™ Spirulina and Verratain™ Omega Oil, which are low-carbon microalgae feed ingredients. When these products are incorporated into the animal's diet as a nutrition source, producers can materially reduce the carbon intensity of animal feed to allow organizations to meet their sustainability goals while supporting animal health. “Our Verratain Verified Sustainability Solutions represent a natural evolution of Phibro’s portfolio as our customers increasingly seek credible, scalable sustainability solutions,” said Dani Bendheim, incoming Chief Executive Officer of Phibro Animal Health Corporation. “These offerings complement our existing animal health and nutrition solutions while directly addressing the evolving sustainability needs of animal protein and petfood producers and their downstream customers.”

Targeting a Major Scope 3 Emissions Hotspot

The World Benchmarking Alliance reports that 165 of the world’s 350 most influential food and agriculture companies have disclosed Scope 3 climate commitments, which typically call for 20–30% reductions in value‑chain emissions by 2030. At scale, this implies an estimated $80–300 billion per‑year decarbonization value signal under SBTi‑aligned internal carbon pricing. (Source: World Business Council for Sustainable Development. 2024. Scope 3 Navigator for Agri-Food. Available: https://cecodes.org.co/wp-content/uploads/2026/02/WBCSD-AF-C-suite-Scope-3-Navigator-deck.pdf Accessed: May 1, 2026).

Feed is typically the largest source of Scope 3 emissions for livestock, poultry and aquaculture producers. By focusing on feeding a low carbon alternative nutrient source, Verratain directly targets one of the most significant emissions drivers in animal protein supply chains.

Verratain Spirulina and Verratain Omega Oil are produced by VAXA Technologies in their proprietary state of the art indoor cultivation platform directly connected to renewable geothermal energy, clean water resources, and controlled growing conditions. The production process yields low‑carbon feed material that is designed to seamlessly integrate with existing feeding systems. The program utilizes life cycle assessment-based solutions to create effective Scope 3 decarbonization which is incorporated into the product’s life-cycle assessments, in accordance with leading international standards such as the Greenhouse Gas Protocol.

Leadership to Build and Scale the Platform

To lead the Sustainable Solutions Platform and the Verratain portfolio, Phibro recently appointed Peter Bunce as Head of Sustainable Solutions. Bunce brings more than two decades of experience in agricultural sustainability and voluntary carbon markets, including building large‑scale programs that connect farmers with downstream consumer packaged goods companies and retailers.

“I joined Phibro because of its deep integration across global protein and dairy supply chains, where scalable solutions can deliver meaningful emissions reductions,” said Bunce. “After many years working in agricultural voluntary emissions markets, I have rarely seen innovations that combine impact and practicality like Verratain.”

Advancing a More Efficient and Resilient Food System

The launch of the Verratain product line marks a pivotal commercial milestone for Phibro’s sustainability initiatives. The Company anticipates the commencement of initial sales within the coming months, providing early adopters with a first-to-market opportunity to integrate these low-carbon microalgae solutions into their production systems.

Looking ahead, Phibro views the Sustainable Solutions Platform as a long‑term growth business that will expand beyond the initial products and partnership. To learn more about Verratain and our science-based solutions or to schedule a call with our sustainability team, please visit us at www.pahc.com/verratain or contact us at verratain@pahc.com.

About VAXA Technologies

VAXA is a food tech / climate tech company that has successfully industrialized its patented, carbon-negative microalgae production platform, to deliver proven, scalable solutions. By leveraging renewable energy, waste streams, and machine learning, VAXA produces high-value ingredients that physically remove emissions from the global supply chain, allowing partners to decarbonize at the source. Unlike traditional, resource-heavy algae production, VAXA’s modular, indoor facility in Iceland achieves a 100x higher decarbonization impact using less than 1% of the resources required by conventional methods, utilizing a bio secured optimized environment to ensure a consistent, food-grade output that provides a reliable, superior supply chain for corporations looking to improve their products and meet their sustainability goals.

For more information on VAXA visit www.vaxa.life / www.vaxaimpact.com.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. The Company strives to be a trusted partner to livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions that help maintain and enhance animal health. For more information, visit www.pahc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260505692758/en/

Contacts:

Contact for Phibro Animal Health Corporation
Phibro Animal Health Corporation
Glenn C. David
Chief Financial Officer
+1-201-329-7300
or
investor.relations@pahc.com

Source: Phibro Animal Health Corporation